AHA 2025
AHA​ 2025 7 - 10 November 2025

Efficacy and safety of semaglutide according to frailty status in the SELECT trial

Authors :

John W. Ostrominski1,2; Jorge Plutzky1; Benjamin M. Scirica1; G. Kees Hovingh3,4; Ole Kleist Jeppesen3 A. Michael Lincoff5; Ildiko Lingvay6; Thomas Hoffmann Morville3; María De Los Angeles Quiroga Peláez3; Yael Sofer7,8; Miguel Urina-Triana9; Vanita R. Aroda9
Affiliations
View Details Hide Details
Download poster (.pdf)
Keywords
Cardiovascular Disease
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)